SCHEMBL1005754

SCHEMBL1005754

Cc1ccc(NC(=O)O)s1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.67
RAB9A P51151 5/20 0.67
SMN1; SMN2 Q16637 5/20 0.67
MAPT P10636 4/20 0.67
NFKB1 P19838 3/20 0.67
TP53 P04637 2/20 0.67
NFKB2 Q00653 2/20 0.67
RELA Q04206 2/20 0.67
GAA P10253 2/20 0.52
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 2/20 0.52
PKM P14618 1/20 0.52
DAO P14920 1/20 0.50
RAF1 P04049 1/20 0.43
KMT2A Q03164 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
POLB P06746 1/20 0.43
CYP1A2 P05177 1/20 0.43
MAPK1 P28482 1/20 0.43
APOBEC3A P31941 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705561 0.85 NFKB1 (0.61) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL14584377 0.84 HSD17B10 (0.75) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL209971 0.84 NFKB1 (0.59) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL5550842 0.83 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL11174292 0.83 NPC1 (0.58) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL11455366 0.79 TP53 (0.54) NPC1RAB9ASMN1; SMN2MAPTNFKB1
Lithium Ion SCHEMBL209972 0.78 NPC1 (0.53) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL208477 0.78 NPC1 (0.53) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL11461143 0.77 MAPT (0.59) NPC1RAB9ASMN1; SMN2MAPTNFKB1
SCHEMBL11462094 0.77 RAB9A (0.51) NPC1RAB9ASMN1; SMN2MAPTNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102066339-B 2, 6-diamino-pyrimidin-5-yl-carboxamides as SYK or JAK protein kinase inhibitors PORTOLA PHARM INC 2014-09-24 CN disclosed
EP-2268281-A1 THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS Abbott Laboratories (US) 2011-01-05 EP disclosed
WO-2009102462-A1 THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2009-08-20 WO disclosed